152 Avsnitt

  1. Medical Affairs Series, Part Five: Medical Affairs in the Early Stage

    Publicerades: 2020-01-10
  2. Real World Evidence and Rare Diseases

    Publicerades: 2019-12-20
  3. The Digital Therapeutics Alliance: A European Perspective

    Publicerades: 2019-12-11
  4. Medical Affairs Series, Part Four: Medical Affairs in the Field

    Publicerades: 2019-11-20
  5. Medical Affairs Series, Part Three: Moving to the Left

    Publicerades: 2019-11-06
  6. Advocacy Archetypes

    Publicerades: 2019-10-24
  7. Medical Affairs Series, Part Two - Measuring the Unmeasurable: Medical Affairs Metrics

    Publicerades: 2019-10-09
  8. Why We Resist

    Publicerades: 2019-09-25
  9. Medical Affairs Series, Part One: A Foundation for Medical Affairs

    Publicerades: 2019-09-11
  10. A Regulatory Roadmap for Real World Evidence

    Publicerades: 2019-08-28
  11. Talented Teams

    Publicerades: 2019-08-14
  12. Digital Therapeutics

    Publicerades: 2019-07-31
  13. Talking About PIE

    Publicerades: 2019-07-17
  14. MOAs in ONC: The Latest and Greatest in the Oncology Pipeline

    Publicerades: 2019-07-03
  15. Episode 037: Psychology in Clinical Trials

    Publicerades: 2019-06-19
  16. Episode 036: Commercialization for Emerging Companies

    Publicerades: 2019-06-05
  17. Episode 035: How Translational Science Can Solve Pharma's Productivity Puzzle

    Publicerades: 2019-05-15
  18. Episode 034: Can the Gut Microbiome Revolutionize Medical Care?

    Publicerades: 2019-05-01
  19. APAC Edition: Medical Affairs in China

    Publicerades: 2019-04-26
  20. Episode 033: From DTC to DT"Me" - The Future of Communications in Pharmaceuticals

    Publicerades: 2019-04-17

6 / 8

The Syneos Health Podcast Series dissects some of the most complex issues biopharma leaders are facing today. Our clinical and commercial experts provide time-tested solutions, as well as perspectives on the news of the day. Each episode explores the challenges and considerations involved with bringing biopharmaceuticals to the market.

Visit the podcast's native language site